Dermata Historical Cash Flow
| DRMA Stock | USD 1.18 0.24 16.90% |
Analysis of Dermata Therapeutics cash flow over time is an excellent tool to project Dermata Therapeutics future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Change In Working Capital of 490.2 K or Begin Period Cash Flow of 7.8 B as it is a great indicator of Dermata Therapeutics ability to facilitate future growth, repay debt on time or pay out dividends.
Dermata |
About Dermata Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Dermata balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Dermata's non-liquid assets can be easily converted into cash.
Dermata Therapeutics Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Most accounts from Dermata Therapeutics' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Dermata Therapeutics current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dermata Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For information on how to trade Dermata Stock refer to our How to Trade Dermata Stock guide.At present, Dermata Therapeutics' Stock Based Compensation is projected to increase significantly based on the last few years of reporting. The current year's Change In Working Capital is expected to grow to about 490.2 K, whereas Change In Cash is projected to grow to (4.1 B).
Dermata Therapeutics cash flow statement Correlations
Click cells to compare fundamentals
Dermata Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Dermata Therapeutics cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | (1.5M) | 10.3M | (4.6M) | 1.2M | (4.3B) | (4.1B) | |
| Stock Based Compensation | 0.0 | 1.9M | 930.3K | 522.1K | 657.6M | 690.5M | |
| Free Cash Flow | (4.0M) | (5.7M) | (8.8M) | (6.4M) | (11.2B) | (10.6B) | |
| Change In Working Capital | (755.8K) | 289.6K | (153.6K) | 863.7K | 466.9K | 490.2K | |
| Begin Period Cash Flow | 2.0M | 530.4K | 10.8M | 6.2M | 7.4B | 7.8B | |
| Other Cashflows From Financing Activities | 3.2M | (430K) | 287.0 | 187.0 | 1.1K | 1.1K | |
| Other Non Cash Items | (36.5K) | 14.1K | 930.3K | 522.1K | 466.4M | 489.7M | |
| Total Cash From Operating Activities | (4.0M) | (5.7M) | (8.8M) | (6.4M) | (11.2B) | (10.6B) | |
| Issuance Of Capital Stock | 268.8K | 16.0M | 4.3M | 5.7M | 6.9M | 7.0M | |
| Net Income | (3.2M) | (7.9M) | (9.6M) | (7.8M) | (12.3B) | (11.7B) | |
| Total Cash From Financing Activities | 2.6M | 16.0M | 4.3M | 7.6M | 6.9M | 7.7M | |
| End Period Cash Flow | 530.4K | 10.8M | 6.2M | 7.4M | 3.2B | 3.3B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dermata Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For information on how to trade Dermata Stock refer to our How to Trade Dermata Stock guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dermata Therapeutics. If investors know Dermata will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dermata Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Dermata Therapeutics is measured differently than its book value, which is the value of Dermata that is recorded on the company's balance sheet. Investors also form their own opinion of Dermata Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Dermata Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dermata Therapeutics' market value can be influenced by many factors that don't directly affect Dermata Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dermata Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dermata Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dermata Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.